AAV vector-mediated muscle directed gene therapy results in long-term enzymatic and functional correction in cardio-vascular system of Fabry mouse

被引:0
|
作者
Takahashi, H
Seino, Y
Fukumoto, H
Hirai, Y
Shimada, T
Takano, T
机构
[1] Nippon Med Coll, Dept Internal Med 1, Tokyo 113, Japan
[2] Nippon Med Coll, Dept Biochem & Mol Biol, Tokyo 113, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
138
引用
收藏
页码:28 / 28
页数:1
相关论文
共 44 条
  • [31] Long-term functional correction after adenovirus-mediated transfer of the mini-dystrophin gene in MDX mice muscle.
    Deconinck, N
    Ragot, T
    Marechal, G
    Perricaudet, M
    Gillis, JM
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1997, 433 (04): : 3 - 3
  • [32] Preemptive gene therapy by AAV-mediated delivery of heme oxygenase-1 results in long-term normalization of left ventricular function and chamber dimensions
    Melo, LG
    Zhang, LN
    Pachori, AS
    Kong, DL
    Davis, PJ
    Solomon, S
    Perrella, MA
    Pratt, RE
    Dzau, VJ
    CIRCULATION, 2003, 108 (17) : 144 - 144
  • [33] Sustained, long-term, correction of neuropathology in a mouse model of Hunter Disease following stem cell gene therapy with an LV.IDS.ApoEII vector.
    Wood, S. R.
    Ellison, S. M.
    Liao, A. Y.
    Gleitz, H. F.
    Mitchell, M.
    Holley, R. J.
    Bigger, B. W.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A48 - A48
  • [34] AAV2/7 and AAV2/8 mediated liver directed gene therapy enables long-term expression of the human LDL receptor and substantially diminishes atherosclerosis in LDL receptor deficient mice
    Lebherz, C
    Gao, GP
    Louboutin, JP
    Millar, J
    Rader, D
    Wilson, JM
    CIRCULATION, 2003, 108 (17) : 143 - 143
  • [35] A single neonatal delivery of an exon 2 directed AAV9.U7snRNA vector results in long-term dystrophin expression that prevents pathologic features in the Dup2 mouse
    Wein, N.
    Simmons, T.
    Gumienny, F.
    Yurkoski, J.
    Huang, N.
    Muntoni, F.
    Flanigan, K.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S126 - S127
  • [36] A Single Neonatal Delivery of an Exon 2 Directed AAV9.U7snRNA Vector Results in Long-Term Dystrophin Expression That Prevents Pathologic Features in the Dup2 Mouse
    Wein, Nicolas
    Simmons, Tabatha R.
    Gumienny, Felecia
    Yurkoski, Jacqueline
    Huang, Nianyuan
    Muntoni, Francesco
    Flanigan, Kevin M.
    MOLECULAR THERAPY, 2016, 24 : S247 - S248
  • [37] Replication-competent retrovirus vector-mediated cancer gene therapy: Highly efficient and tumor-specific transfer of suicide genes in vivo resulting in tumor eradication and long-term survival
    Tai, CK
    Wang, WJ
    Logg, CR
    Sazawa, A
    Faure, E
    Anderson, WF
    Chen, TC
    Kasahara, N
    MOLECULAR THERAPY, 2003, 7 (05) : S314 - S315
  • [38] Long-Term Disease Correction and Reduced Liver Tumorigenesis Using Hybrid Recombinant AAV-Piggybac Transposon Mediated Gene Therapy in the Progressive Familial Intrahepatic Cholestasis Type 3 (PFIC3) Mouse Model in vivo
    Siew, Susan M.
    Zhu, Erhua
    Tay, Szun
    Cunningham, Sharon C.
    Alexander, Ian E.
    HEPATOLOGY, 2017, 66 : 365A - 366A
  • [39] Single-intrathecal delivery of a new AAV9-mediated gene therapy vector provides long-term safe expression of frataxin and prevents neurological and cardiac deficits, neurodegeneration and iron deposition in a Friedreich's Ataxia mouse model
    Balague, E.
    Cota-Gonzalez, D.
    Adrian-Campbell, K.
    Garcia-Lareu, B.
    Bosch, A.
    Coll-Canti, J.
    Chillon, M.
    Sanchez, I.
    Matilla-Duenas, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 89 - 90
  • [40] Long-term, sustained efficacy and safety from a phase 1/2 clinical trial of an AAV8-mediated liver-directed gene therapy in adults with glycogen storage disease type Ia
    Pico, M. L. Couce
    Mitchell, J.
    Ahmad, A.
    Olmos, M.
    Derks, T. G.
    Riba-Wolman, R.
    Weinstein, D. A.
    Rodriguez-Buritica, D. F.
    Lee, C.
    Valayannopoulos, V.
    Crombez, E.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A28 - A28